The Prospect

Join Boehringer Ingelheim at a pivotal moment to shape the future of obesity and metabolic health. This rare launch role will see you shaping the launch and commercialisation of Survodutide, a next‑generation therapy with the potential to redefine patient outcomes. You will lead end‑to‑end brand strategy for a pre‑launch and launch asset, translating insight into action and building a focused market entry strategy in a competitive and rapidly evolving market.

The role offers solid career progression, with the chance to step into a future leadership position and build and lead a high‑performing brand team as the franchise grows.

Key Responsibilities

Launch & Brand Strategy
Lead development and execution of the end‑to‑end launch readiness for Survodutide in Australia
Build and implement Integrated Customer Plans aligned to pre‑launch and launch milestones
Develop segmentation, targeting and positioning strategies grounded in deep customer insight




Define value proposition and messaging across obesity and metabolic health stakeholders

Commercial Planning & Performance
Develop robust launch scenarios and business cases aligned to launch readiness and ICP
Monitor brand performance and optimise investment based on ROI and market dynamics
Lead competitive intelligence to inform strategic decision‑making in a fast‑moving market

Cross‑functional Leadership
Act as the central connector across Medical, Market Access, Sales, Regulatory, and regional teams
Lead agency partners to deliver best‑in‑class omnichannel campaigns
Support field force readiness, including value communication and customer engagement frameworks

Execution Excellence
Deliver high‑impact omnichannel campaigns, congress strategy, and customer engagement plans
Ensure all activities meet

📌 Senior Brand Manager Cardio, Renal, Metabolic New Product Launch City Of Sydney
🏢 Boehringer Ingelheim
📍 City of Sydney